| Clinuvel Pharmaceuticals Limited: CLINUVEL implements strategic reorganisation to refocus on U.S. markets | MELBOURNE, Australia and NEW YORK, July 23, 2026 (GLOBE NEWSWIRE) -- CLINUVEL PHARMACEUTICALS LTD (ASX: CUV | Nasdaq: CUVL) today announced a strategic reorganisation of its operations and workforce... ► Artikel lesen |
| Clinuvel Pharmaceuticals Limited: CLINUVEL receives final EMA scientific advice for pivotal Phase III vitiligo study | EXECUTIVE SUMMARY final European scientific advice received for pivotal Phase III vitiligo studyEMA emphasised its "totality of evidence" approachcentral photographic review and validated disease... ► Artikel lesen |
| Original-Research: CLINUVEL Pharmaceuticals Limited (von Parmantier & Cie. GmbH): Buy | Original-Research: CLINUVEL Pharmaceuticals Limited - from Parmantier & Cie. GmbH
26.03.2026 / 12:45 CET/CEST
Dissemination of a Research, transmitted by EQS News - a service of EQS Group.
The... ► Artikel lesen |
| Auxly Cannabis Group Inc.: Auxly Reports Second Quarter 2026 Results | TORONTO, Aug. 13, 2026 /PRNewswire/ -- Auxly Cannabis Group Inc. (TSX: XLY) (OTCQB: CBWTF) ("Auxly" or the "Company") a leading consumer packaged goods company... ► Artikel lesen |
| Auxly Cannabis Group Inc.: Auxly Announces Commencement of Trading Following 14:1 Share Consolidation | TORONTO, July 28, 2026 /PRNewswire/ -- Auxly Cannabis Group Inc. (TSX: XLY) (OTCQB: CBWTF) ("Auxly" or the "Company") announces the outstanding common shares in... ► Artikel lesen |
| XFRA NEW INSTRUMENTS AVAILABLE ON 28.07.2026 | The following instruments on XETRA do have their first trading 28.07.2026 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 28.07.2026
Aktien
1 PLBEST000010 BEST S.A.
2 IT0005720500... ► Artikel lesen |